FDA SBIR Phase I grant awarded to Triple Ring Technologies
NEWARK, Calif., Oct. 19, 2021 /PRNewswire/ --Triple Ring Technologies, a co-development firm that helps innovators and entrepreneurs develop breakthrough science-based technologies, is pleased to announce that the company has been awarded an SBIR Phase I grant by the Food and Drug Administration entitled An e-beam sterilization dose map simulation tool.